PITTSBURGH, March 15, 2018 /PRNewswire/ -- "I am a home health-care professional, and I almost fell on the floor while attending to a patient," said an inventor from Lithonia, Ga. "To prevent slips and falls, I came up with a way to contain the water while bathing an individual seated on a shower chair."
She created a prototype for the WATER SHIELD to contain the water used to bathe and rinse an individual seated on a shower chair. The accessory prevents the water from spilling onto the floor. This keeps the floor free of puddles. The invention thereby reduces the risk of slips and falls, which is designed to enhance personal safety. Additionally, the device is easy to use.
The original design was submitted to the Atlanta office of InventHelp. It is currently patent pending and available for licensing or sale to manufacturers or marketers. For more information, write Dept. 16-AAT-3041, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced it has raised a $21 million investment in the first close of its Series B fundraising round. The funding has been secured from several new investors;...
Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS. This innovative solution streamlines medical image management within clinical...
SOPHiA GENETICS , a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Nigeria-based Syndicate Bio has signed on to implement MSK-ACCESS® powered with SOPHiA DDMtm. Syndicate Bio is the...
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...
